TELA Bio Inc

TELA

Company Profile

  • Business description

    TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. Its growing product portfolio is purposefully designed to leverage the patient’s natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

  • Contact

    1 Great Valley Parkway
    Suite 24
    MalvernPA19355
    USA

    T: +1 484 320-2930

    E: [email protected]

    https://www.telabio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    209

Stocks News & Analysis

stocks

Meta earnings: Strong end to 2025 as AI monetization begins to show

Investors please with latest results.
stocks

Why doesn’t the market like the earnings from this US tech giant?

Good quarter with AI demand ramping.
stocks

Our Tesla fair value increases meaningfully

Progress on Robotaxi and Optimus shows real world AI growth.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,236.906.40-0.07%
CAC 408,110.9444.260.55%
DAX 4024,580.60242.19-0.98%
Dow JONES (US)49,015.6012.190.02%
FTSE 10010,227.4272.990.72%
HKSE27,968.09141.180.51%
NASDAQ23,857.4540.350.17%
Nikkei 22553,375.6016.890.03%
NZX 50 Index13,348.6164.26-0.48%
S&P 5006,978.030.57-0.01%
S&P/ASX 2008,927.504.300.05%
SSE Composite Index4,157.986.750.16%

Market Movers